Detailed answers about CYTOLYSIS PHARMA UK LIMITED, including incorporation, status, business activity, and accounts information.
When was CYTOLYSIS PHARMA UK LIMITED founded?
CYTOLYSIS PHARMA UK LIMITED was officially incorporated on 16 April 2026 and is registered under company number 17161836. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CYTOLYSIS PHARMA UK LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CYTOLYSIS PHARMA UK LIMITED?
CYTOLYSIS PHARMA UK LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CYTOLYSIS PHARMA UK LIMITED do?
CYTOLYSIS PHARMA UK LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is CYTOLYSIS PHARMA UK LIMITED's registered address?
The registered office address of CYTOLYSIS PHARMA UK LIMITED is 128 City Road, London, United Kingdom, EC1V 2NX. This is the official address filed with Companies House for legal and statutory correspondence.
Is CYTOLYSIS PHARMA UK LIMITED financially stable?
Financial accounts for CYTOLYSIS PHARMA UK LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.